PARAMUS, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with…
The DEA Regulatory Revolving Door Spins AgainAfter years of blocking FDA approved cannabis research for Huntington's and Multiple Sclerosis, former…
Constitutional Earthquake: The End of the DEA's In-House CourtDOJ's reversal on administrative law judge protections vindicates MMJ BioPharma's constitutional challenge…
Provides comprehensive, AI-powered solutions to help states deliver sustainable, high-quality healthcare in rural communities Offers recommendations to states seeking to…
CONSHOHOCKEN, Pa., Oct. 7, 2025 /PRNewswire/ -- Suvoda (recently merged with Greenphire), a global clinical trial technology company specializing in software…
Metabolon's best-in-class metabolomics leadership accelerates as metabolomics becomes a standard inclusion in global multiomics studies MORRISVILLE, N.C., Oct. 7, 2025…
RealTime eClinical Solutions co-authors industry-first guide for sponsor-site collaboration on technology choice. SAN ANTONIO, Oct. 7, 2025 /PRNewswire/ -- When…
FAYETTEVILLE, Ark., Oct. 7, 2025 /PRNewswire/ -- HeartX, powered by HealthTech Arkansas and MedAxiom — along with dozens of leading…
In this free webinar, learn how biomarkers and digital tools are improving clinical trials in neurodegenerative diseases. Attendees will understand the…
Calgary, Alberta--(Newsfile Corp. - October 7, 2025) - Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is…